在患有慢性心力衰竭的患者中对心肌收缩调节装置的临床观察
Hongfei Song1, Rui Yang1, Wenwei Bai1
1Department of Cardiology, The Second Affiliated Hospital of Kunming Medical University.
International heart journal
|July 30, 2025
概括
这项研究表明,左心室心脏收缩性调节 (CCM) 在慢性心力衰竭 (HF) 患者中显著改善心脏功能和生活质量,这些患者仅仅对药物反应不佳.
科学领域:
- 心脏病学 心脏病学
- 生物医学工程 生物医学工程
背景情况:
- 心力衰竭 (HF) 影响全球超过2500万,中国有890万病例.
- 针对高血压的优化药物治疗往往无法预防持续的症状和重新入院.
- 对于先进的HF治疗策略存在重大未满足的需求.
研究的目的:
- 为了评估左心室心脏收缩度调制 (CCM) 装置的疗效.
- 评估CCM对药物耐药HF患者心脏功能和生活质量的影响.
- 分析心声回声学参数,生物标志物和CCM植入后的运动耐受性变化.
主要方法:
- 一个涉及5名慢性心力衰竭患者的病例系列.
- 植入左心室心脏收缩度调制 (CCM) 装置.
- 在1个月和6个月后进行术后随访,以评估结果.
主要成果:
- 在CCM植入后1个月和6个月观察到心脏功能显著改善.
- 患者在生活质量方面经历了显著的改善.
- 心声学参数,心肌生物标志物和运动耐受性显示出积极的变化.
结论:
- 左心室心脏收缩性调制 (CCM) 为晚期心力衰竭提供了一个有前途的治疗选择.
- CCM可以提高心脏表现,改善药物治疗不响应患者的健康状况.
- 需要进一步的研究来探索CCM的长期益处和更广泛的适用性.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
23
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
23
Heart Failure Drugs: Inotropic Agents
728
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
728
Cardiomyopathy V: Interprofessional Care
34
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
Cardiomyopathy III: Hypertrophic Cardiomyopathy
52
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
52
Pulse rhythm
929
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
929
Heart Failure V: Medical Management
25
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
25


